Crescent Capital BDC (NASDAQ:CCAP) Receives New Coverage from Analysts at LADENBURG THALM/SH SH

LADENBURG THALM/SH SH began coverage on shares of Crescent Capital BDC (NASDAQ:CCAP) in a research note published on Monday morning, MarketBeat.com reports. The brokerage issued a buy rating and a $20.00 price objective on the stock.

A number of other equities analysts have also weighed in on CCAP. Bank of America decreased their target price on Crescent Capital BDC from $20.00 to $19.00 and set a buy rating for the company in a research report on Thursday, August 15th. Wells Fargo & Company decreased their target price on Crescent Capital BDC from $19.00 to $18.00 and set an equal weight rating for the company in a research report on Wednesday, August 14th. One research analyst has rated the stock with a hold rating and five have given a buy rating to the company. According to data from MarketBeat.com, Crescent Capital BDC presently has an average rating of Moderate Buy and an average target price of $19.00.

Crescent Capital BDC Stock Performance

Shares of Crescent Capital BDC stock opened at $18.25 on Monday. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.17. The firm has a market capitalization of $676.38 million, a P/E ratio of 6.49 and a beta of 0.81. The business has a fifty day simple moving average of $18.35 and a two-hundred day simple moving average of $18.17. Crescent Capital BDC has a 12 month low of $15.03 and a 12 month high of $19.63.

Crescent Capital BDC (NASDAQ:CCAP) last posted its quarterly earnings results on Monday, August 12th. The company reported $0.59 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.58 by $0.01. The firm had revenue of $48.95 million during the quarter, compared to analyst estimates of $48.05 million. Crescent Capital BDC had a return on equity of 12.03% and a net margin of 51.61%. During the same quarter in the previous year, the firm earned $0.56 EPS. On average, equities analysts forecast that Crescent Capital BDC will post 2.34 earnings per share for the current fiscal year.

Crescent Capital BDC Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, October 15th. Stockholders of record on Monday, September 30th will be given a dividend of $0.42 per share. This is an increase from Crescent Capital BDC’s previous quarterly dividend of $0.09. This represents a $1.68 dividend on an annualized basis and a dividend yield of 9.21%. The ex-dividend date is Monday, September 30th. Crescent Capital BDC’s dividend payout ratio is currently 59.79%.

Institutional Trading of Crescent Capital BDC

A number of institutional investors have recently bought and sold shares of CCAP. Sun Life Financial Inc. lifted its position in Crescent Capital BDC by 8.1% in the second quarter. Sun Life Financial Inc. now owns 1,843,766 shares of the company’s stock worth $34,626,000 after buying an additional 137,684 shares during the last quarter. Confluence Investment Management LLC purchased a new stake in Crescent Capital BDC in the first quarter worth $1,200,000. Millennium Management LLC increased its stake in Crescent Capital BDC by 31.9% in the second quarter. Millennium Management LLC now owns 268,097 shares of the company’s stock worth $5,035,000 after purchasing an additional 64,902 shares during the period. Deerfield Management Company L.P. Series C purchased a new stake in Crescent Capital BDC in the second quarter worth $1,021,000. Finally, Muzinich & Co. Inc. purchased a new stake in Crescent Capital BDC in the fourth quarter worth $843,000. 49.46% of the stock is currently owned by institutional investors.

Crescent Capital BDC Company Profile

Crescent Capital BDC, Inc is as a business development company private equity / buyouts and loan fund. It specializes in directly investing. It specializes in middle market. The fund seeks to invest in United States.